Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1997-3-31
pubmed:abstractText
Patients with AIDS-related lymphoma usually have extensive lymphomatous disease, with relatively frequent involvement of the CNS. Approximately half may achieve complete remission after chemotherapy. Mitoguazone, an inhibitor of polyamine biosynthesis, has demonstrated efficacy in patients with de novo recurrent lymphoma. The drug is relatively nonmyelotoxic and may cross the blood-brain barrier. The current study was designed to assess the safety and potential efficacy of mitoguazone in patients with relapsed or refractory AIDS-lymphoma.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1094-103
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9060550-Adult, pubmed-meshheading:9060550-Aged, pubmed-meshheading:9060550-Antineoplastic Agents, pubmed-meshheading:9060550-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:9060550-Drug Administration Schedule, pubmed-meshheading:9060550-Drug Resistance, Neoplasm, pubmed-meshheading:9060550-Female, pubmed-meshheading:9060550-Humans, pubmed-meshheading:9060550-Infusions, Intravenous, pubmed-meshheading:9060550-Lymphoma, AIDS-Related, pubmed-meshheading:9060550-Male, pubmed-meshheading:9060550-Middle Aged, pubmed-meshheading:9060550-Mitoguazone, pubmed-meshheading:9060550-Neutropenia, pubmed-meshheading:9060550-Recurrence, pubmed-meshheading:9060550-Remission Induction, pubmed-meshheading:9060550-Survival Analysis, pubmed-meshheading:9060550-Thrombocytopenia
pubmed:year
1997
pubmed:articleTitle
Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial.
pubmed:affiliation
University of Southern California School of Medicine, Los Angeles 90033, USA. hornor@hsc.usc.edu
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Multicenter Study, Clinical Trial, Phase II